Cuba vs Portugal: HIV/AIDS deaths averted by antiretroviral therapy
Cuba
1,468 deaths
in 2024
Portugal
1,420 deaths
in 2024
Cuba rank
65th
Portugal rank
66th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cuba
- Portugal
How they compare
Cuba currently reports 1,468 deaths against 1,420 deaths in Portugal, a difference of 48 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Portugal ahead.
Cuba ranks 65th and Portugal ranks 66th of 157 countries.
Across the 4 decades both report, Cuba averaged higher in 1 and Portugal in 3.
Head to head by decade
| Decade | Cuba | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 125.06 deaths | 125.06 deaths | Portugal |
| 2000s | 292.14 deaths | 1,361 deaths | 1,069 deaths | Portugal |
| 2010s | 1,136 deaths | 1,650 deaths | 513.74 deaths | Portugal |
| 2020s | 1,525 deaths | 1,458 deaths | 66.35 deaths | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cuba or Portugal?
- Cuba, at 1,468 deaths against 1,420 deaths in Portugal as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cuba and Portugal?
- 48 deaths, with Cuba ahead.
- How many years of comparable data are there for Cuba and Portugal?
- 35 years are reported by both, from 1990 to 2024.
- How do Cuba and Portugal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cuba ranks 65th and Portugal ranks 66th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.